Drugs / human derived umbilical cord derived mesenchymal stem cells
human derived umbilical cord derived mesenchymal stem cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT04951882 Comparator | Jun 2021 → Dec 2022 | acute lung injury | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human derived umbilical cord derived mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04951882 ↗ |
| Modality | Cell therapy | “intravenous transplantation of human derived umbilical cord derived mesenchymal stem cells” NCT04951882 ↗ |
| Route | Intravenous | “intravenous transplantation of human derived umbilical cord derived mesenchymal stem cells” NCT04951882 ↗ |